AV’s LOCUST® Selected for Nearly $500 million Army Counter-UAS Contract for Enduring-High Energy Laser (E-HEL) Program

AeroVironment (AVAV) was awarded a $464.8 million U.S. Army contract for the Enduring-High Energy Laser (E-HEL) program. The deal is described as the first-ever production contract for directed energy systems in U.S. history, a milestone for the sector and likely to strengthen AVAV’s defense backlog and revenue visibility. Market impact is likely meaningful given the large contract size and historic nature of the award.

Analysis

AVAV just shifted from being valued as a niche autonomy/counter-UAS story to a credible platform beneficiary of a new budget category. The market should care less about first-year revenue contribution and more about the validation effect: once a service puts a novel effect on production footing, follow-on lots, depot support, and allied procurement can dominate the economics. That is the setup for multiple expansion, because defense investors pay for program legitimacy and scarcity of capability, not just near-term bookings.

The second-order winners are the subsystems that make directed energy deployable at scale: power conversion, thermal management, beam control, and ruggedized sensing. Larger primes may end up as partners or integrators if they lack a mature stack, while smaller kinetic counter-drone vendors face the risk of slower budget growth in certain short-range air defense use cases as lasers become a lower-cost-per-shot alternative. The substitution is not immediate or universal, but it can quietly cap growth rates in adjacent interceptor and effector franchises.

The contrarian point is that this is still a procurement signal, not proof of scalable unit economics. Startup production on new defense technologies often drags margins before it improves them, so the first question is whether AVAV can convert this into recurring lots without a working-capital or gross-margin hit. Near term, momentum can persist for days to weeks; over 1-3 months the thesis depends on guidance and backlog conversion, and over 6-18 months on whether the Army repeats funding beyond a single demonstrator line.

Key Decisions for Investors

• Buy AVAV on any 3-5% post-news pullback; target a 15-20% move over 1-3 months if management confirms backlog conversion, and cut if the next earnings call does not mention follow-on production or if the stock loses the post-announcement breakout level.
• Prefer an AVAV bull call spread into the next earnings cycle over outright equity if implied volatility stays elevated; the reward is rerating on program validation, not an immediate EPS step-up.
• Relative-value idea: long AVAV / short XAR or ITA for 1-3 months to isolate the directed-energy rerating from general defense beta; invalidate if the broad defense tape is lifted by a macro/geopolitical risk-on bid.
• Watch RTX, NOC, LHX, and KTOS for teaming or subsystem disclosures; those would confirm budget expansion into directed energy and could extend the theme beyond AVAV.